Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells

Carcinogenesis

Volumn 20, Issue 12, 1999, Pages 2237-2246

  Shabalina, Irina G ^a   Panaretakis, Theoharis ^a   Bergstrand, Anders ^b   DePierre, Joseph W ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CELL DNA; DNA FRAGMENT; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR; PROPIDIUM IODIDE; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN HEPG2; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ELECTRON MICROSCOPY; ELECTROPHORESIS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; MITOSIS; NUCLEOSOME; PRIORITY JOURNAL;

EID: 0033390728     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.12.2237     Document Type: Article

References (51)

1. Abdelattif, A.G., Preat, V., Taper, H.S. and Roberfroid, M. (1991) The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol. Appl. Pharmacol., 111, 530-537.
2. Sohlenius, A.K., Andersson, K., Bergstrand, A., Spydevold, O. and DePierre, J.W. (1994) Effects of perfluorooctanoic acid - a potent peroxisome proliferator in rat - on Morris hepatoma 7800C1 cells, a rat cell line. Biochim., Biophys. Acta, 1213, 63-74.
3. Sohlenius, A.K., Eriksson, A.M., Högström, C., Kimland, M. and DePierre, J.W. (1993) Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver. Pharmacol. Toxicol., 72, 90-93.
4. Sohlenius, A.K., Lundgren, B. and DePierre, J.W. (1992) Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver. J. Biochem. Toxicol., 7, 205-212.
5. Moody, D.E. and Reddy, J.K. (1978) Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds. Toxicol. Appl. Pharmacol., 45, 497-504.
6. Moody, D.E. and Reddy, J.K. (1978) The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes. Am. J. Pathol., 90, 435-450.
7. Lalwani, N.D., Reddy, M.K., Qureshi, S.A., Sirtori, C.R., Abiko, Y. and Reddy, J.K. (1983) Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Hum. Toxicol., 2, 27-48.
8. Cohen, A.J. and Roe, F.J. (1997) Evaluation of the aetiological role of dietary salt exposure in gastric and other cancers in humans. Food Chem. Toxicol., 35, 271-293.
9. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
10. Stott, W.T. (1988) Chemically induced proliferation of peroxisomes: implications for risk assessment. Regul. Toxicol. Pharmacol., 8, 125-159.
11. Conway, J.G., Cattley, R.C., Popp, J.A. and Butterworth, B.E. (1989) Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate. Drug Metab. Rev., 21, 65-102.
12. Nilsson, R., Beije, B., Préat, V., Erixon, K. and Ramel, C. (1991) On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Chem. Biol. Interact., 78, 235-250.
13. Green, S. (1991) The search for molecular mechanisms of non-genotoxic carcinogens. Mutat. Res., 248, 371-374.
14. Moody, D.E., Reddy, J.K., Lake, B.G., Popp, J.A. and Reese, D.H. (1991) Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fundam. Appl. Toxicol., 2, 233-248.
15. Reddy, J.K. and Rao, M.S. (1989) Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res., 214, 63-68.
16. Kasai, H., Okada, Y., Nishimura, S., Rao, M.S. and Reddy, J.K. (1989) Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49, 2603-2605.
17. Marsman, D.S., Cattley, R.C., Conway, J.G. and Popp, J.A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in rats. Cancer Res., 48, 6739-6744.
18. Yeldandi, A.V., Milano, M., Subbarao, V., Reddy, J.K. and Rao, M.S. (1989) Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett., 47, 21-27.
19. Kraupp-Grasl, B., Huber, W., Taper, H. and Schulte-Hermann, R. (1991) Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res., 51, 666-671.
20. Schulte-Hermann, R., Bursch, W. and Parzefall, W. (1991) Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds. Prog. Clin. Biol. Res., 369, 237-244.
21. Heady, J.A., Morris, J.N. and Oliver, M.F. (1992) WHO clofibrate/cholesterol trial: clarifications. Lancet, 340, 1405-1406.
22. Huttunen, J.K., Heinonen, O.P., Manninen, V., Koskinen, R., Hakulinen, T., Teppo, L., Mänttäri, M. and Frick, M.H. (1994) The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J. Intern. Med., 235, 31-39.
23. Bieri, F., Bentley, P., Waechter, F. and Stäubli, W. (1984) Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator. Carcinogenesis, 5, 1033-1039.
24. Perrone, C.E., Shao, L. and Williams, G.M. (1998) Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis and apoptosis in cultured human and rat hepatocytes. Toxicol. Appl. Pharmacol., 150, 277-286.
25. Canuto, R., Muzio, G., Bonelli, G., Maggiora, M., Autelli, R., Barbiero, G., Costelli, R., Brossa, O. and Baccino, F.M. (1998) Peroxisome proliferators induce apoptosis in hepatoma cells. Cancer Detect. Prevent., 22, 357-366.
26. Aden, D.P., Fogel, A., Plotkin, S., Damjanov, I. and Knowles, B.B. (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 282, 615-616.
27. Wyllie, A.H. (1980) Glucocorticoids-induced thymocyte apoptosis is associated with endonuclease activation. Nature, 284, 555-556.
28. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Meth., 139, 271-279.
29. Duke, R.C., Chervenak, R. and Conen, J.J. (1983) Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc. Natl Acad. Sci. USA, 80, 6361-6365.
30. Telford, W.G., King, L.E. and Fraker, P.J. (1992) Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry, 13, 137-143.
31. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. and Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808.
32. Jonker, R.R., Bauman, J.G.J. and Visser, J.M.W. (1992) Detection of apoptosis using non-radioactive in situ nick translation. In NATO Advanced Study Institutes Programme. New Developments in Flow Cytometry. Lectures Option C. CNRS, Villejuif, pp. 30-31.
33. Roberts, R.A. (1996) Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators. Ann. NY Acad. Sci., 804, 588-611.
34. Bayly, A.C., Roberts, R.A. and Dive, C. (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell. Biol., 125, 197-203.
35. Bursch, W., Dusterberg, B. and Schulte-Hermann, R. (1986) Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch. Toxicol., 59, 221-227.
36. Jiang, M.C., Yang-Yen, H.F., Lin, J.K. and Yen, J.J. (1996) Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene, 13, 609-616.
37. Bae, S.K., Baek, J.H., Lee, Y.M., Lee, O.H. and Kim, K.W. (1998) Hypoxia-induced apoptosis in human hepatocellular carcinoma cells: a possible involvement of the 6-TG-sensitive protein kinase(s)-dependent signaling pathway. Cancer Lett., 126, 97-104.
38. Keller, B.J., Marsman, D.S., Popp, J.A. and Thurman, R.G. (1992) Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta, 1102, 237-244.
39. Cai, Y., Appelkvist, E.L. and DePierre, J.W. (1995) Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators. J. Biochem. Toxicol., 10, 87-94.
40. Reddy, J.K., Azarnoff, D.L. and Hignite, C.E. (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature, 283, 397-398.
41. Reddy, J.K. and Rao, M.S. (1987) Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health. Arch. Toxicol. Suppl., 10, 43-53.
42. Cai, J. and Jones, D.P. (1998) Superoxide in apoptosis. J. Biol. Chem., 1273, 11401-11404.
43. Susin, S.A., Zamzami, N. and Kroemer, G. (1998) Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta, 1366, 151-165.
44. Xia, Z., Karlsson, H., DePierre, J.W. and Nässberger, L. (1997) Tricyclic antidepressants induce apoptosis in human T lymphocytes. Int. J. Immunopharmacol., 19, 645-654.
45. Levitt, D. and Liss, A. (1986) Toxicity of perfluorinated fatty acids for human and murine B cell lines. Toxicol. Appl. Pharmacol., 86, 1-11.
46. Levitt, D. and Liss, A. (1987) Perfluorinated fatty acids alter merocyanine 540 dye binding to plasma membranes. J. Toxicol. Environ. Health, 20, 303-316.
47. Pasilly, P., Jannin, B., Hassell, S.J. and Latruffe, N. (1996) Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry. Exp. Cell Res., 223, 436-442.
48. 2. Exp. Cell Res., 223, 259-267.
49. Leszczynski, D. (1995) Regulation of cell cycle and apoptosis by protein kinase C in rat myeloid leukemia cell line. Oncol. Res., 7, 471-480.
50. Chi, C.W., Chang, Y.F., Chao, T.W., Chiang, S.H., Peng, F.K., Lui, W.Y. and Liu, T.Y. (1994) Flow cytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells. Life Sci., 54, 2099-2107.
51. Ahmad, N., Feyes, D.K., Nieminen, A.L., Agarwal, R. and Mukhtar, H. (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl Cancer Inst., 89, 1881-1886.